A case of spontaneous splenic rupture causing hemorrhagic shock in a 74-year-old on Apixaban
DOI:
https://doi.org/10.18203/2349-2902.isj20262999Keywords:
Spontaneous splenic rupture, Traumatic splenic rupture, Apixaban, Direct oral anticoagulants, Hemorrhagic shock, SplenectomyAbstract
Spontaneous splenic rupture is a rare, life-threatening cause of atraumatic intra-abdominal hemorrhage and may occur in patients receiving anticoagulation. We present a 74-year-old woman with atrial fibrillation treated with apixaban who presented with one day of worsening abdominal pain and near-syncope without preceding trauma. She was hypotensive on arrival, with hemoglobin of 5.8 g/dl, elevated lactate, and acute kidney injury. Computed tomography (CT) of the abdomen and pelvis demonstrated a lower-pole splenic laceration with active contrast extravasation, subcapsular hematoma, and hemoperitoneum. She underwent immediate resuscitation with intravenous fluids, packed red blood cells, and prothrombin complex concentrate for anticoagulant reversal, followed by emergent exploratory laparotomy. Operative findings confirmed hemoperitoneum and an actively bleeding spleen with capsular avulsion; splenectomy was performed. Her postoperative course included intensive care monitoring, additional transfusion support, temporary pharmacologic thromboprophylaxis that was discontinued because of incisional bleeding, and post-splenectomy vaccination. She was discharged on postoperative day 7 without anticoagulation pending cardiology follow-up and remained clinically well at subsequent postoperative visits. This case highlights spontaneous splenic rupture as an important diagnostic consideration in anticoagulated patients presenting with unexplained abdominal pain, anemia, or hemodynamic instability despite no history of trauma. Prompt imaging, anticoagulant reversal, resuscitation, and definitive operative management are critical to survival, while post-hemorrhage anticoagulation decisions require individualized multidisciplinary assessment.
References
Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D. Systematic review of atraumatic splenic rupture. Br J Surg. 2009;96(10):1114-21.
Moore EE, Cogbill TH, Jurkovich GJ, Shackford SR, Malangoni MA, Champion HR. Organ injury scaling: spleen and liver (1994 revision). J Trauma. 1995;38(3):323-4.
Chin-Yee N, Gomes T, Tanuseputro P, Talarico R, Laupacis A. Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study. CMAJ. 2022;194(35):E1198-208.
Ballestri S, Romagnoli E, Arioli D, Coluccio V, Marrazzo A, Athanasiou A, et al. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review. Adv Ther. 2023;40(1):41-66.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65.
Gündeş E, Aday U, Çiyiltepe H, Çetin DA, Bozdağ E, Senger AS, et al. Spontaneous splenic rupture related to anticoagulant and antiaggregant treatment. Prz Gastroenterol. 2019;14(2):152-6.
Sabe AA, Claridge JA, Rosenblum DI, Lie K, Malangoni MA. The effects of splenic artery embolization on nonoperative management of blunt splenic injury: a 16-year experience. J Trauma. 2009;67(3):565-72.
Giagounidis AA, Burk M, Meckenstock G, Koch AJ, Schneider W. Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann Hematol. 1996;73(6):297-302.
Haan JM, Biffl W, Knudson MM, Davis KA, Oka T, Majercik S, et al. Splenic embolization revisited: a multicenter review. J Trauma. 2004;56(3):542-54.
Leiss W, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, et al. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med. 2015;30(1):17-24.
Takeuchi M, Nakano S, Tanaka-Mizuno S, Nishiyama C, Doi Y, Arai M, et al. Adherence and Concomitant Medication Use among Patients on Warfarin Therapy: Insight from a Large Pharmacy Dispensing Database in Japan. Biol Pharm Bull. 2019;42(3):389-93.
Kocael PC, Osman S, Bilgin IA, Tutar O, Saribeyoglu K, Pekmezci S, et al. Characteristics of patients with spontaneous splenic rupture. Int Surg. 2014;99:714-8.
Nguyen T, Worsley D, Ma D. Nontraumatic splenic rupture in anticoagulated patients: A case series and literature review. Am J Emerg Med. 2015;33(9):1213.e5-e8.
Hyun KH, Kim J, Bae JH. Spontaneous splenic rupture associated with anticoagulation therapy: A case report and review of the literature. Int J Surg Case Rep. 2017;34:84-7.
Cherry WB, Mueller PS. Rectus sheath hematoma: review of 126 cases at a single institution. Medicine (Baltimore). 2006;85(2):105-10.
De Caterina R, Ammentorp B, Darius H, Lip GYH. Management of bleeding complications in patients on oral anticoagulants: Clinical guidance from the Anticoagulation Forum. J Thromb Thrombolysis. 2020;50(2):301-21.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-67.
Patrono C, Morais J, Baigent C, Collet JP, Fitzgerald D, Halvorsen S, et al. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. J Am Coll Cardiol. 2017;70(14):1760-76.
Witt DM, Delate T, Garcia DA, Clark NP, Hylek EM. Resuming anticoagulation after major bleeding: a systematic review and meta-analysis. Am J Hematol. 2016;91(1):11-6.